P2RY12 and transient ischemic attack: Platelet Reactivity in Acute Non-disabling Cerebrovascular Events (PRINCE) trial showed that ticagrelor had a lower proportion of HOPR assessed by VerifyNow P2Y12 assay than clopidogrel in patients with minor stroke and TIA [18].